High grade glioma patients had higher CSF and serum levels of sB7-H3 and sPD-L1 compared to low grade glioma; however, their serum levels in glioma patients did not significantly differ from healthy controls (229). The gene discussed is SPDL1; the disease is central nervous system cancer.